Where does Kure, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Kure, LLC ranks #36,171 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Kure, LLC hold?

Kure, LLC holds 7 US utility patents granted between 2020 and 2025, spanning 10 technology areas.

What is Kure, LLC's Innovation Score?

Kure, LLC has an Innovation Score of 48.4 out of 100 (top 17% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Kure, LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Kure, LLC.

What does claim depth mean for Kure, LLC's patents?

Kure, LLC's patents average 16.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Kure, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Kure, LLC

Q: What technology areas does Kure, LLC focus on?

Kure, LLC's top technology area is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data) with 5 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 10 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Kure ranks #36,171 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 10 technology areas.

#36,171
of 49,997 US assignees by volume: Top 17%
by Innovation Score (48.4/100): 16.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R36171 · US Corporation #36,171 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #36,171/49,997
PHOTO-FINISH Kuantag Nanoteknoloj…
CPC-FOCUS G16H · 10 areas
INNOV-PAR 48.4/100
CLAIMS-RICH 16.7 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Kuantag Nanoteknolojiler Gelistirme VE Uretim A.S. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Kure · this assignee

48
3D Lighting… · lowest

7

What this shows Kure's Innovation Score is 48.4/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Kure's grants concentrate

Kure, LLC is a focused PatentsView assignee: 10 CPC subclasses with 71.4% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2020. By volume, Kure sits between Kuantag Nanoteknolojiler Gelistirme VE Uretim A.S. and Kyoto Semiconductor Co., Ltd..

Kure's three-year grant acceleration

Kure, LLC shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Kuantag Nanotekno…

7
Kuhn Krause

7
Kuiu

7
Kuka Systems Nort…

7
Kuros Biosciences

7
Kyocera SOC

7
Kyoto Pharmaceuti…

7
Kyoto Semiconduct…

7
Kure ◀

7

What this shows Kure holds 7 patents at rank #36,111, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Kure

By rank, the assignees closest to #36,111 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Kure's primary technology class.

Kure's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Kure, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	14.3%
2022	1	14.3%
2023	3	42.9%
2024	1	14.3%
2025partial year	1	14.3%

Which technologies does Kure, LLC patent most?

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 5

G06F - Electric Digital Data Processing 3

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 2

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 2

G07C - Time OR Attendance REGISTERS; Registering OR Indicating THE Working OF MACHINES; Generating Random NUMBERS; Voting OR Lottery APPARATUS; Arrangements, Systems OR Apparatus FOR Checking NOT Provided FOR Elsewhere 2

A61B - DIAGNOSIS; SURGERY; Identification 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

H04W - Wireless Communication Networks 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#36,171

of 49,997 tracked assignees

Innovation Score

48.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Kure, LLC's patent record in context - here's where to go next.

Kure, LLC's lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 71.4% of its portfolio - see every assignee active in that class. Explore G16H
Ranked #36,171 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Kure, LLC against Kuantag Nanoteknolojiler Gelistirme VE Uretim A.S., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.